Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. H.W. (Hans) Nijman

Publicaties

Diagnostic accuracy of MRI, CT, and [18F]FDG-PET-CT in detecting lymph node metastases in clinically early-stage cervical cancer — a nationwide Dutch cohort study

ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors.

A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases

Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors

Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET

Incidence of gynaecological cancer during the COVID-19 pandemic: A population-based study in the Netherlands

Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts

Prognostic benefit of TILs independent of clinicopathological and molecular factors

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

Stage, treatment and survival of low-grade serous ovarian carcinoma in the Netherlands: A nationwide study

Lees meer

Pers/media

Ziekenhuiskoepel ziet uitwerking concentratieplannen kankerzorg niet zitten

Kankerzorg straks in minder ziekenhuizen: ‘Niet alle zorg kan meer om de hoek'

‘Niemand kan achteroverleunen’

UMCG ontvangt subsidie voor onderzoek naar immuuntherapie bij baarmoederkanker

Hoogleraar UMCG maakt plan kankerzorg voor Zorginstituut Nederland

Oncoloog Hans Nijman is kwartiermaker netwerk- en expertzorg kanker

„Werk aan de winkel met kankerpreventie”

Subsidie voor minder belastende behandeling schaamlipkanker

Onderzoek naar minder belastende behandeling schaamlipkanker

Subsidie voor minder belastende behandeling schaamlipkanker

Lees meer